For clinics with Schedule I-III licenses, D amp M Pharma Peru SAC can provide opioids and psychotropics, following Peru’s Narcotic Drugs and Psychotropic Substances Law.
In the rapidly evolving landscape of the Peruvian pharmaceutical market, few names have garnered as much attention among industry insiders as . As a specialized entity operating within the highly regulated framework of Peruvian health and commerce laws, this company has positioned itself as a potential key player in the supply chain of medical supplies, generic drugs, and specialized treatments.
Beyond chemical drugs, "Pharma" entities often distribute medical devices, surgical sutures, and diagnostic reagents. If D & M Pharma deals in cold-chain products (vaccines or insulin), they must maintain strict temperature-controlled warehouses. d amp m pharma peru sac
For international suppliers, partnering with D amp M Pharma Peru SAC offers a gateway to Peru’s growing healthcare market. For local clinics and hospitals, the company provides reliability in a sector where product quality can be a matter of life and death. As Peru continues to modernize its healthcare system, expect this name to appear more frequently in tender announcements and industry directories.
(Desarrollos y Marketing Farmacéutico) is a leading pharmaceutical and medical wholesaler in Peru specializing in the commercialization, import, and distribution of high-quality dermatological, respiratory, and ophthalmological products . Founded on August 1, 2007 , the company serves as the Peruvian subsidiary of the regional D&M Pharma Group , which originally launched in Chile in 2003. By partnering with renowned global manufacturing companies—such as Argentina’s Laboratorio Cassará —D&M Pharma Peru S.A.C. bridges the gap between complex pharmaceutical developments and the localized healthcare needs of medical specialists and patients across Peru. Corporate Profile & Operational Core For clinics with Schedule I-III licenses, D amp
is a prominent pharmaceutical enterprise based in Lima, Peru, specializing in the wholesale distribution, commercialization, and marketing of advanced medical, dermatological, and respiratory solutions. Incorporated on August 1, 2007, the company acts as a crucial strategic hub for the broader D&M Pharma Group across the South American Pacific coast. It bridges the gap between top-tier regional laboratory production and local healthcare needs. Corporate Origins and Regional Footprint
: Retinoid-based gels (Adapalene) formulated for localized acne treatments. 3. Novoplos Division (Ophthalmology) For local clinics and hospitals, the company provides
Through its rigorous implementation of sanitary standards, targeted product diversification, and deep alignment with Latin American manufacturing powerhouses, D&M Pharma Peru S.A.C. remains a crucial player in elevating the availability of specialized, high-tier medicine across Peru.
While specific operational details are not public without a full SUNAT (Peru’s tax authority) or Registros Públicos search, companies with “Pharma” in their name in Peru typically register for activities such as:
Understanding D&M Pharma Peru S.A.C.: Operations, Portfolio, and Market Role